0000000000623752

AUTHOR

L. Piroth

Human Immunodeficiency Virus Continuum of Care in 11 European Union Countries at the End of 2016 Overall and by Key Population: Have We Made Progress?

Abstract Background High uptake of antiretroviral treatment (ART) is essential to reduce human immunodeficiency virus (HIV) transmission and related mortality; however, gaps in care exist. We aimed to construct the continuum of HIV care (CoC) in 2016 in 11 European Union (EU) countries, overall and by key population and sex. To estimate progress toward the Joint United Nations Programme on HIV/AIDS (UNAIDS) 90-90-90 target, we compared 2016 to 2013 estimates for the same countries, representing 73% of the population in the region. Methods A CoC with the following 4 stages was constructed: number of people living with HIV (PLHIV); proportion of PLHIV diagnosed; proportion of those diagnosed …

research product

Emergence des pathologies pulmonaires non infectieuses chez les patients vivant avec le virus de l’immunodéficience humaine (VIH) : étude sur la base nationale des données du PMSI de 2007 à 2013

Introduction Une modification de l’epidemiologie des pathologies respiratoires a ete constatee chez les patients infectes par le VIH depuis la mise en place des therapies antiretrovirales. Les objectifs de notre travail sont de determiner la prevalence francaise des pathologies respiratoires chez les personnes infectees par le VIH et d’evaluer le risque que represente l’infection par le VIH dans la survenue de pathologies respiratoires non infectieuses. Methodes A partir de la base nationale de donnees du Programme de medicalisation des systemes d’information (PMSI), nous avons calcule la prevalence hospitaliere d’un panel de pathologies respiratoires chez les patients infectes par le VIH h…

research product

Factors associated with 12 week case-fatality in Staphylococcus aureus bacteraemia: a prospective cohort study

International audience; Staphylococcus aureus bacteraemia (SAB) is a frequent and deadly disease. Given the lack of a randomized trial, optimal first-line antibiotic treatment is still debated. Our aim was to identify prognostic factors in SAB patients and to analyse the impact of first-line antibiotics. The VIRSTA prospective cohort study was conducted in eight tertiary care centres in France. Consecutive incident adults in whom a blood culture drawn in participating centres grew S. aureus between April 2009 and October 2011 were prospectively followed for 12 weeks. Factors associated with 12-week case-fatality were identified by multivariate logistic regression. We enrolled 2091 patients …

research product